Simultaneous measurement of dozens of types of fats in the blood ('lipidomics') can predict the risk of developing type 2 diabetes (T2D) and cardiovascular disease (CVD) years in the future, according to a new study. Such early prediction through lipidomic profiling may provide the basis for recommending diet and lifestyle interventions before disease develops.
